Objectives: Traditional antibiotic therapy of staphylococcal osteomyelitis by a single drug or a drug combination is ineffective in producing complete sterilization of infected bones. The aim of this study was to develop a non-traditional delivery system of antibiotics for treatment of chronic experimental osteomyelitis.
Introduction
Osteomyelitis is an infective process in bone and bone marrow, 1 characterized by chronic morbidity. 2 Delivery of the microorganism to the bone tissues might take place during direct contamination, as in trauma and surgery, or during haematogenous or contiguous spread. 3 The persistence of this disease despite antibiotic chemotherapy 4 might be attributed to the poor antibiotic accumulation in the bone tissues, 5 impaired local immune response, negative effects of slime, changes in rate of bacterial growth and intracellular localization of the pathogens. 6 Therefore, the development of a new strategy or regimen for targeting antimicrobial agents to bone tissues is urgent. Animal models of chronic osteomyelitis 1, 7 similar to that of humans should be used in testing the efficacy of different antimicrobial agents. There are no reliable data in the literature relating to the optimal duration of antimicrobial therapy, the efficacy of one drug versus another and the relative contributions of surgery and antibiotics to 'success or failure' in the treatment of osteomyelitis. 8 Liposomes have been extensively used as carriers of antimicrobial and antineoplastic drugs. 9 They are usually produced from naturally occurring, biodegradable and non-toxic phospholipids. 10 Liposomes have been designed to release drugs into an extracellular or intracellular compartment to reach their site of action. 11 The ability of liposomes to alter drug distribution depends largely on their size and surface properties. 11 Thus, liposomal encapsulation of antibiotics is a drug delivery system that helps to increase the therapeutic index of the antibiotics by increasing the concentration of the drug at the site of infection and/or reducing the toxicity. 12 Organs rich in cells from the reticuloendothelial system (RES) preferentially take up liposomes, e.g. liver, spleen, lung and bone marrow. 9 antibiotic to bone marrow might achieve a high concentration of the drug in bone tissues. For extracellular bacteria, the enhanced antibacterial effect may be due to a fusion mechanism of the liposomal formulation with bacteria. Intracellularly infected phagocytic cells demonstrate that the phagocytosis of antibiotic-loaded liposomes yields therapeutic intracellular drug concentrations and consequently enhanced killing of intracellular microorganisms, such as Staphylococcus aureus, Escherichia coli, Brucella abortus and Mycobacterium avium.
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The present study was concerned with the establishment of a new strategy for antibiotic therapy against chronic staphylococcal osteomyelitic infection in rabbits. Therapeutic trials compared the ability of the liposomal form of ciprofloxacin and vancomycin alone and in combination for 7 and 14 days to sterilize the infected bones. In addition, the study was undertaken to promote more efficient liposome -bacterium interaction, by testing liposomal formulations of varying characteristics regarding the size and the membrane electric charge. To the best of our knowledge, no study has yet been conducted using liposomal antibiotics for the treatment of S. aureus osteomyelitis infection.
Materials and methods

Bacterial strains and preparation of inocula
A clinical strain of S. aureus isolated from a patient with chronic osteomyelitis as well as a standard strain (ATCC 29213) were used throughout this investigation. To prepare the inocula of bacterial suspensions, bacteria were grown for 18 h in trypticase soy broth (TSB), 1 mL of which was added to 10 mL of TSB and incubated for 5 h at 378C to obtain exponential phase bacteria. Bacterial concentration was adjusted by spectrophotometry (A 450 ) thereafter to the desired cfu/mL of phosphate buffered saline (PBS). 2 
Preparation of liposomes
Liposomes were prepared as previously described by Ravaoarinoro et al. 13 Briefly, three liposomal compositions were formulated: lecithin (egg phosphatidyl chloine), stearylamine and cholesterol (cationic liposomes); lecithin, La-phosphatidyl-DL-glycerol and cholesterol (anionic liposomes); and lecithin and cholesterol (neutral liposomes). The molar ratio was 7:2:1, respectively, for charged liposomes, whereas it was 7:1 for neutral preparations. Lipid mixtures were dissolved in chloroform in a round-bottomed flask and dried to a thin lipid film with a rotary evaporator (Heidolph WB2000, Germany) in high vacuum at 408C. The lipids were then hydrated by agitation in 6 mL of an aqueous solution of antibiotics at 20 mg/mL concentration for 1 h at 558C. To manipulate the in vitro effect of liposomal particle size, lipid suspensions, submerged in an ice bath, were sonicated for 20, 40, 60 or 80 s in an ultrasonic bath (Braun-Sonic 200; Braun Instruments, Burlingame, CA, USA). Unencapsulated antibiotic was removed by centrifugation at 60 000 g for 1 h at 48C in a Beckman ultracentrifuge (Optima-MAX-E; Beckman Coulter Inc., Palo Alto, CA, USA). The final pellets were resuspended in 6 mL of distilled water, and the liposomal preparations stored at 48C to be used in the same week. Cholesterol, La-phosphatidyl-DL-glycerol, egg lecithin and stearylamine were obtained from Sigma Co. (St Louis, MO, USA).
Determination of encapsulation efficiency
Encapsulation efficiency of charged or neutral liposomes was calculated as the percentage of antibiotic incorporated in liposomes relative to the initial total amount of antibiotic in solution. Antibiotic assay was performed by radial diffusion from wells cut in Mueller -Hinton agar (Oxoid) with a lawn of S. aureus ATCC 29213, and the antibiotic concentration was determined from the standard curve. Intra-liposomal antibiotic was calculated by two methods: first, by measuring the concentration of unentrapped antibiotic detected in supernatant after centrifugation of the liposomal preparation at 60 000 g for 1 h and subtracting this from the initial total concentration of antibiotic. The other method depended on rupturing the liposomes by adding 100 mL of 1% Triton X-100 (Sigma) in Tris/saline buffer to 400 mL of the liposomal suspension to release the entrapped antibiotic. 14 
Susceptibility testing
The MICs of antibiotics in free or in liposomal form were determined against the clinical as well as the standard strain (ATCC 29213) of S. aureus by an agar dilution method. 15 A 4 h culture in TSB was diluted and an inoculum of 10 4 -10 5 cfu per spot was obtained on Mueller -Hinton agar plates containing different dilutions of antibiotic. After incubation for 18 h at 378C, the plates were examined visually for the presence or absence of bacterial growth. MICs were recorded as the lowest concentrations of antibiotics that inhibited bacterial growth. All MIC determinations were performed in duplicate to ensure reproducibility of results.
Effect of liposomal size on antibacterial activity
Antibacterial activities of different liposomal formulations sonicated for different times (20, 40 , 60 or 80 s) the against the standard strain of S. aureus (ATCC 29213) were determined in wells by an agar diffusion method. The experiments were performed three times and the results expressed as the mean of inhibition zone diameters in mm.
Induction and evaluation of osteomyelitis
Sixty-five New Zealand white rabbits, weighing 4 -5 lb, were anaesthetized 16 intravenously with phenobarbitone (30 mg/kg) and intramuscularly with ketamine (10 mg/kg). The left legs were shaved and disinfected with povidone iodine (Betadine). The proximal medial surface of the tibia was surgically exposed and a hole made through the cortex by a high-speed drill equipped with a 1.2 mm bit. 3 Five microlitres of 50 mL/mL arachidonic acid (Sigma Co.), which acts as a sclerosing agent, was injected into the marrow cavity with a 10 mL Hamilton microsyringe (Hamilton Co., Reno, NE, USA), followed by 5 mL of S. aureus (2 Â 10 6 cfu) 1,2 and 0.1 mL of sterile saline to assure complete entry of the bacteria into the marrow. Drill holes were sealed with sterile bone wax (Ethicon Sutures Ltd, Peterborough, Ontario, Canada), and the incisions were closed with sutures. A negative control group of animals underwent the same surgical treatment as described above (including the sclerosing agent) but received 0.1 mL of sterile normal saline solution instead of S. aureus. At weekly intervals, all rabbits were weighed. Osteomyelitis was evaluated by palpation, sinus formation and pus discharge, and by radiology. Two observers independently examined X-rays of the infected tibiae for evidence of osteomyelitis 2 weeks after injection and at weekly intervals thereafter. The severity of disease was determined according to the scale of 0 -3 described by Norden et al. 17 The in vivo study adhered to the principles and ethical standards of laboratory animal care that are approved by the Research Center at the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Conduct of therapeutic trials
Since radiological changes in chronic osteomyelitis were present at day 14, treatment at this time was considered to represent therapy for chronic osteomyelitis. 7 Therapy was instituted 14 days after infection and given for 14 days. The rabbits still alive were divided into 10 groups (six in each); each group received one of the following regimens: (i) no antibiotic therapy; (ii) twice daily injection of ciprofloxacin (10 mg/kg); (iii) twice daily injection of vancomycin (15 mg/kg); (iv) twice daily injection of vancomycin and ciprofloxacin at doses mentioned above; (v) twice daily injection of ciprofloxacin (10 mg/kg) in liposomal form; (vi) twice daily injection of vancomycin (15 mg/kg) in liposomal form; (vii) twice daily injection of ciprofloxacin and vancomycin in liposomal form at the doses mentioned above. In addition, the three liposomal forms of the antibiotics were tried for 7 days. All injections were given intravenously. All rabbits were killed at the end of the experiments after blood samples had been taken. Bone marrow specimens were weighed, suspended in 2 mL of sterile PBS (pH 7.4), and agitated by vigorous vortexing to dislodge the organisms attached; if any. 18 Blood samples and bone marrow specimens were cultured on Mueller -Hinton agar plates for bacterial growth.
Renal function and antibiotic therapy
The serum urea and creatinine levels were measured after a 2 week course of antibiotic therapy.
Results
Effect of liposomal charge on antibiotic entrapment
The percentage of ciprofloxacin and vancomycin trapped in cationic, anionic and neutral liposomes is shown in Table 1 .
A greater percentage of each antibiotic was trapped within charged liposomes than within neutral liposomes.
Susceptibility testing
MICs of antibiotic-loaded liposomes compared with free antibiotics against S. aureus strains are shown in Table 2 . With the exception of cationic liposomal forms, other formulations yielded MICs equal to or higher than those obtained with the free drug. MICs obtained with cationic liposomes matched those obtained with the free drug or were one or two dilutions lower.
Effect of liposomal size on antibacterial activity
The results shown in Table 3 indicate that positively charged liposomal preparations of antibiotics sonicated for 40 s gave the highest antibacterial activity against the standard strain (S. aureus ATCC 29213) by agar diffusion.
In vivo therapeutic trials with liposomal formulations of antibiotics
Injection of arachidonic acid alone produced no gross or radiological evidence of osteomyelitis. Only rabbits injected with arachidonic acid and the clinical isolate of S. aureus developed radiological evidence of osteomyelitis. Some widening and distortion of normal bone architecture can be seen in Figure 1 (a) compared with a control tibia shown in Figure 1(b) . Out of 65 rabbits injected with 2 Â 10 6 S. aureus, five rabbits (7.7%) died within 14 days of injection. Cultures of bone from all five dead rabbits yielded the injected S. aureus.
The results of therapy are shown in Table 4 . With no antibiotic therapy, all infected animals had positive blood and bone cultures when killed at the end of the experiments. Treatment with free ciprofloxacin or vancomycin for 14 days was ineffective in eradicating osteomyelitis. In contrast, the combination of both drugs in free form for 14 days was more effective than either agent alone. Only two rabbits (33.3%) of the group given a combination therapy in free form for 14 days showed sterile bones on culture. In addition, two rabbits died before the end of therapy in the same group. Treatment with either ciprofloxacin or vancomycin in liposomal form for 7 days was ineffective in sterilizing infected rabbit bones, but was significantly better when administered for 14 days. Sterility of all bone cultures was observed only with the group treated with a combination of ciprofloxacin and vancomycin in liposomal form for 14 days (Table 4) . 
Renal function and antibiotic therapy
The serum urea and creatinine levels were measured 2 weeks after therapy. As shown in Table 5 , rabbits that received a combination of free ciprofloxacin and vancomycin therapy for 14 days often developed severe diarrhoea and renal dysfunction. This situation resulted from the mean serum urea and creatinine of this group, which were shown to be significantly different from the control group and from the group that received liposomal combination therapy.
Discussion
Osteomyelitis is a disease known to be persistent and refractory to conventional antibiotic therapy, 4 because of low antibiotic penetration to the site of infection.
Previous studies with a rabbit model of staphylococcal osteomyelitis have shown that the use of single antibiotics in free form, including ciprofloxacin and vancomycin, or in combination with another antibiotic, is only moderately effective in sterilizing infected rabbit bones. 17 -22 The animal model poses a difficult challenge for any antimicrobial agents because to be considered successful in clinical trials it requires sterilization of the infected bone. 23 The aim of this study was to develop a new regimen for treating a rabbit model of chronic staphylococcal osteomyelitis by antibiotics encapsulated in liposomes. Liposomes offer a safe and convenient means to control the rate and location by which drugs are delivered within the body. Liposomal size and surface charges can be manipulated and optimized for each therapeutic application. 11 A major problem in the targeting of intravenously injected liposomes to the mononuclear phagocytes of the bone marrow is their rapid and efficient removal by the RES of Kupffer cells of the liver and macrophages of the spleen. 24 Thus one of our goals in this study was the reduction of RES uptake of liposomes by liver and spleen by means of surface charge and size modification, and hence a substantially prolonged blood circulation time. The results presented in Table 1 demonstrate that Figure 1 . Radiographs of (a) tibia taken 14 days after infection, and (b) control non-infected tibia. ciprofloxacin and vancomycin could be incorporated within anionic, cationic and neutral liposomes. The highest entrapment that was observed with cationic followed by anionic liposomes supports the view that the presence of charged lipid increases the aqueous space with liposomes. The encapsulation efficiency of both drugs in cationic liposomes was $ 9% higher than that of anionic liposomes (Table 1) . Moreover, the in vitro activity of anionic and neutral liposomes containing ciprofloxacin or vancomycin was reduced against the clinical isolate of S. aureus compared with the free forms of the drugs (Table 2) . However, the cationic liposomal formulations of these drugs enhanced their in vitro activity against the clinical isolate, and yielded MICs equal or lower than those obtained with the free drug ( Table 2) . Such enhancement could be explained on the basis that, in cationic liposomes, the external molecules supply a positive charge to vesicles. Thus, interaction of negatively charged bacterial cell surfaces with cationic liposomes might take place. 25 In addition, positively charged liposomes are cleared less rapidly from the circulation than negatively charged liposomes. 26 To obtain a uniform and reproducible liposomal particle size between 50 -100 nm, the method described by Omri et al. 15 was followed. Liposomes <100 nm in diameter are less efficiently taken up by the RES and may have a considerably longer mean residence time in plasma, 11 which would be an advantage for treatment of osteomyelitis. Liposomal size produced by sonication for 40 s was the most efficient preparation in vitro (Table 3) . Based on the in vitro studies, cationic liposomes sonicated for 40 s appear to be an interesting carrier and should be considered for further evaluation in vivo.
In the present study, all untreated rabbits had positive cultures when killed at the end of experiments. Treatment with either free ciprofloxacin or vancomycin for 14 days was ineffective in sterilizing the bones of rabbits with staphylococcal osteomyelitis. The combination of both drugs in free form was more effective in sterilizing infected bones than either agent alone. Despite some cures seen (33.3%) in the experimental osteomyelitis group treated with a combination of free drugs (Table 4) , these cannot be taken to imply a recommendation for treatment of chronic osteomyelitis with free antibiotics alone. 7 Adjuvant therapy such as surgery is recommended. 27 Administration of either ciprofloxacin or vancomycin alone or in combination in liposomal form for 7 days was proposed in this study to determine the usefulness of short-term unconventional therapy.
A short course would reduce the cost, toxicity and the inconvenience to patients as liposomal preparations are administered intravenously. These trials showed monotherapy was insufficient to sterilize bone (Table 4) . Administration of a combination of both drugs in liposomal form for 7 days, or either drug alone in liposomal form for 14 days was more effective, but did not sterilize all bone tissues (Table 4) . A combination of ciprofloxacin and vancomycin administered in liposomal form for 14 days sterilized the bones of all treated animals. These results are significantly better than those described in other studies which used single or combination therapy. 17 -22 One of the possible explanations for the relative success of the combination of both drugs in liposomal form might be their ability to penetrate into macrophages and RES in concentrations high enough to cause sterilization of the bones. Moreover, the cationic liposomal forms prolonged the circulation time and decreased the uptake of drugs in liposomal form by macrophages in the liver or spleen. Ciprofloxacin, in free form, is generally well tolerated with relatively low occurrence of adverse reactions. 28 Among the adverse reactions induced by free vancomycin therapy are: severe watery diarrhoea and renal impairment manifested by increasing serum urea and creatinine, especially in patients exposed to a high dose of vancomycin. 29 Because of renal dysfunction, the dose and duration of vancomycin administration are limited. 29 Protection of kidneys might permit the administration of high doses of vancomycin for longer periods. The study revealed that, combination therapy in liposomal form is significantly better than combination therapy in free form in reducing drug toxicity. The data shown in Table 5 revealed that liposomal encapsulation of drugs has a profound effect on reduction of nephrotoxicity associated with these formulations. This significant reduction appears to correlate with decreased renal drug uptake 11 and modification in drug distribution. 9 In conclusion, it seems likely that a combination therapy of ciprofloxacin and vancomycin in liposomal form for 2 weeks will be a valuable addition to therapeutic regimens for chronic osteomyelitis caused by S. aureus and should be considered in future for clinical trials in human osteomyelitis. 
